Consumer Watchdog: Affordable Access to CIRM -Financed Therapies Threatened
The California stem cell agency is proposing a “tremendous loophole” that will allow biotech companies to escape requirements to ensure affordable access to stem cell therapies generated by taxpayer dollars, the Consumer Watchdog group said today.
The group also complained that the regulations are being rushed through a meeting this week of the CIRM boar…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.